DKC1 gene mutation in a Taiwanese kindred with X-linked dyskeratosis congenita

Kaohsiung Journal of Medical Sciences

Volumn 18, Issue 11, 2002, Pages 573-577

  Lin, Jeng Hsien ^a   Yu Yun Lee, J ^a   Tsao, Chao Jung ^a   Chao, Sheau Chiou ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

DKC1; Dyskeratosis congenita; Dyskerin; Mutation; Pancytopenia; X linked

Indexed keywords

DYSKERIN; PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

ADULT; AGING; ALOPECIA; ARTICLE; CANCER; CASE REPORT; CENTROMERE; DKC1 GENE; DYSKERATOSIS CONGENITA; ENTEROCOLITIS; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE; GENE MUTATION; HUMAN; LEUKOPLAKIA; MALE; MICROTUBULE; NAIL DYSTROPHY; PANCYTOPENIA; RNA SYNTHESIS; SEPSIS; SKIN PIGMENTATION; TAIWAN; X CHROMOSOME LINKED DISORDER;

ADULT; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, X; DYSKERATOSIS CONGENITA; HUMANS; LINKAGE (GENETICS); MALE; MUTATION; NUCLEAR PROTEINS; TELOMERE;

EID: 0036865917     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000;110:768-9.
2. Drachtman RA, Alter BP. Dyskeratosis congenita. Dermatol Clin 1995;13:33-9.
3. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998;19:32-8.
4. Collins K. Mammalian telomeres and telomerase. Curr Opin Cell Biol 2000;12:378-83.
5. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999;402:551-5.
6. Shay JW, Wright WE. Mutant dyskerin ends relationship with telomerase. Science 1999;86:284-5.
7. Marciniak RA, Johnson FB, Guarente L. Dyskeratosis congenita, telomeres and human ageing. Trends Genet 2000;16:193-5.
8. Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: Restrictive pulmonary disease and a novel mutation. Thorax 2001;56:891-4.
9. Knight SW, Vulliamy TJ, Morgan B, et al. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: Implications for pathophysiology and diagnosis. Hum Genet 2001;108:299-303.
10. Chien YL, Yang JH, Liu HN. Dyskeratosis congenita: A case report. Derm Sinica 1991;9:159-65.
11. Yaghmai R, Kimyai-Asadi A, Rostamiani K, et al. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr 2000;136:390-3.
12. Alter BP. Molecular medicine and bone marrow failure syndromes. J Pediatr 2000;136:275-6.
13. Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenital gene, DKC1. Br J Haematol 1999; 107:335-9.
14. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in the autosomal dominant dyskeratosis congenita. Nature 2001;413:432-5.
15. Dokal I. Dyskeratosis congenita: Recent advances and future directions. J Pediatr Hematol Oncol 1999;21:344-55.
16. Oulton R, Harrington L. Telomeres, telomerase, and cancer: Life on the edge of genomic stability. Curr Opin Oncol 2000; 12:74-81.
17. de Lange T, Jacks T. For better or worse? Telomerase inhibition and cancer. Cell 1999;98:273-5.
18. McGrath JA. Dyskeratosis congenita: A new clinical and molecular insight into ribosome function. Lancet 1999;353:1204-5.